Lyra Therapeutics, Inc. (LYRA)
1.49
+0.09
(+6.43%)
USD |
NASDAQ |
Feb 19, 16:00
1.42
-0.07
(-4.70%)
Pre-Market: 20:00
Lyra Therapeutics Total Liabilities (Quarterly) : 48.04M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 13.62M |
| BioStem Technologies, Inc. | 12.38M |
| Iovance Biotherapeutics, Inc. | 202.66M |
| Protokinetix, Inc. | 0.2272M |
| GB Sciences, Inc. | 5.974M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.71M |
| Shareholders Equity (Quarterly) | -4.328M |
| Debt to Equity Ratio | -7.250 |
| Current Ratio | 2.428 |
| Net Debt Paydown Yield | 12.42% |